bexarotene

Bexarotene is has been used off-label for non-small cell lung cancer[3] and breast cancer. Bexarotene is an antineoplastic (anti-cancer) agent approved by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).. Reference standards of Bexarotene API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => 1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene-13C4
    [catalogue_number] => PA STI 071830
    [category_ids] => ,80,71,98,78,70,82,99,
    [chemical_name] => 
    [weight] => 206.31
    [form] => C1113C4H22
    [cas] => 1391053-02-3
    [pslug] => 1391053-02-3-1-1-4-4-6-pentamethyl-1-2-3-4-tetrahydronaphthalene-13c4-pasti071830
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)